secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2026-04-22T23:59:59+00:00
Accession:  0001193125-26-168395
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA secures $50M credit facility from largest stockholder affiliate to fund operations into Q1 2028
--------------------------------------------------------------------------------

- $50M revolving credit facility from Parkview (affiliate of largest stockholder) at 12% interest, matures April 2031.
- Monthly draws capped at greater of $1.7M or monthly budget; expects runway into Q1 2028.
- Commitment fee $5M paid in 1.88M shares (subject to stockholder approval) or cash; annual 1.5% facility fee.
- Granted low-to-mid single digit royalty on IFx-2.0 sales up to $450M/year; warrants extended to 2031.
- Change of control conversion price $2.662/share, requires stockholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526168395/0001193125-26-168395-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312526168395/d139552d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-168395

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer